Literature DB >> 24146070

Parameters for sample size estimation from a group-randomized HIV prevention trial in HIV clinics in sub-Saharan Africa.

Jun Zhang1, Sherri L Pals, Amy Medley, Catherine Nichols, Pam Bachanas, Deon van Zyl, Frieda Katuta, James Juma.   

Abstract

Sample size calculations for a group-randomized trial (GRT) require an estimate of the expected intraclass correlation coefficient (ICC). However, few ICC estimates from GRTs in HIV/AIDS research have been published, leaving investigators with little data on which to base expectations. We used data from a multi-country study to estimate ICCs for variables related to physical and mental health and HIV risk behaviors. ICCs for perceptions of physical and mental health tended to be higher than those for HIV risk behavior variables, which were higher than ICCs for CD4 count. Covariate adjustment for country and socio-demographic variables reduced most ICC estimates. For risk behavior variables, adjustment for country and socio-demographic variables reduced ICC estimates by as much as 84 %. Variability in ICC estimates has important implications for study design, as a larger ICC reduces power. ICC estimates presented in this analysis will allow more precise sample size estimates for future GRTs.

Entities:  

Mesh:

Year:  2014        PMID: 24146070      PMCID: PMC4664162          DOI: 10.1007/s10461-013-0631-9

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  21 in total

1.  A Monte Carlo study of alternative responses to intraclass correlation in community trials. Is it ever possible to avoid Cornfield's penalties?

Authors:  D M Murray; P J Hannan; W L Baker
Journal:  Eval Rev       Date:  1996-06

2.  Methods to reduce the impact of intraclass correlation in group-randomized trials.

Authors:  David M Murray; Jonathan L Blistein
Journal:  Eval Rev       Date:  2003-02

3.  CONSORT statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2004-03-20

4.  Randomization by cluster. Sample size requirements and analysis.

Authors:  A Donner; N Birkett; C Buck
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

Review 5.  Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004.

Authors:  Cynthia M Lyles; Linda S Kay; Nicole Crepaz; Jeffrey H Herbst; Warren F Passin; Angela S Kim; Sima M Rama; Sekhar Thadiparthi; Julia B DeLuca; Mary M Mullins
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

6.  Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group.

Authors:  M J Wawer; N K Sewankambo; D Serwadda; T C Quinn; L A Paxton; N Kiwanuka; F Wabwire-Mangen; C Li; T Lutalo; F Nalugoda; C A Gaydos; L H Moulton; M O Meehan; S Ahmed; R H Gray
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

7.  The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda.

Authors:  Maria A Quigley; Anatoli Kamali; John Kinsman; Ignatius Kamulegeya; Jessica Nakiyingi-Miiro; Sylvia Kiwuwa; Jane F Kengeya-Kayondo; Lucy M Carpenter; James A G Whitworth
Journal:  AIDS       Date:  2004-10-21       Impact factor: 4.177

8.  Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial.

Authors:  A L Fontanet; J Saba; V Chandelying; C Sakondhavat; P Bhiraleus; S Rugpao; C Chongsomchai; O Kiriwat; S Tovanabutra; L Dally; J M Lange; W Rojanapithayakorn
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

9.  Evaluation of a targeted HIV prevention programme among female commercial sex workers in the south of Thailand.

Authors:  G J van Griensven; B Limanonda; S Ngaokeow; S I Ayuthaya; V Poshyachinda
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

10.  HIV prevention in care and treatment settings: baseline risk behaviors among HIV patients in Kenya, Namibia, and Tanzania.

Authors:  Daniel P Kidder; Pam Bachanas; Amy Medley; Sherri Pals; Harriet Nuwagaba-Biribonwoha; Marta Ackers; Andrea Howard; Nick Deluca; Redempta Mbatia; Muhsin Sheriff; Gilly Arthur; Frieda Katuta; Peter Cherutich; Geoffrey Somi
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more
  5 in total

1.  Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania.

Authors:  Dale Barnhart; Ellen Hertzmark; Enju Liu; Ester Mungure; Aisa N Muya; David Sando; Guerino Chalamilla; Nzovu Ulenga; Till Bärnighausen; Wafaie Fawzi; Donna Spiegelman
Journal:  Contemp Clin Trials Commun       Date:  2016-09-14

2.  Sample size estimation and re-estimation of cluster randomized controlled trials for real-time feedback, debriefing, and retraining system of cardiopulmonary resuscitation for out-of-hospital cardiac arrests.

Authors:  Akiko Kada; Akihiro Hirakawa; Fumie Kinoshita; Yumiko Kobayashi; Toshihiro Hatakeyama; Daisuke Kobayashi; Chika Nishiyama; Taku Iwami
Journal:  Contemp Clin Trials Commun       Date:  2019-01-04

3.  Mobile Health-Supported HIV Self-Testing Strategy Among Urban Refugee and Displaced Youth in Kampala, Uganda: Protocol for a Cluster Randomized Trial (Tushirikiane, Supporting Each Other).

Authors:  Carmen Logie; Moses Okumu; Robert Hakiza; Daniel Kibuuka Musoke; Isha Berry; Simon Mwima; Peter Kyambadde; Uwase Mimy Kiera; Miranda Loutet; Stella Neema; Katie Newby; Clara McNamee; Stefan D Baral; Richard Lester; Joshua Musinguzi; Lawrence Mbuagbaw
Journal:  JMIR Res Protoc       Date:  2021-02-02

Review 4.  Behavioral interventions for improving contraceptive use among women living with HIV.

Authors:  Laureen M Lopez; Thomas W Grey; Mario Chen; Julie Denison; Gretchen Stuart
Journal:  Cochrane Database Syst Rev       Date:  2016-08-09

5.  Positive deviance for dual-method promotion among women in Uganda: study protocol for a cluster randomized controlled trial.

Authors:  Hodaka Kosugi; Akira Shibanuma; Junko Kiriya; Ken Ing Cherng Ong; Stephen Mucunguzi; Conrad Muzoora; Masamine Jimba
Journal:  Trials       Date:  2020-03-17       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.